Target intelligence / Profile preview

Acetoacetyl-CoA synthetase (AACS)

Target
AACS
Molecular classification
Enzyme, Acyl-CoA synthetase family (Member of the ANL superfamily of adenylate-forming enzymes)
01

Overview

Acetoacetyl-CoA synthetase (AACS) is a cytosolic enzyme that catalyzes the ligation of acetoacetate with CoA using ATP, resulting in the production of acetoacetyl-CoA, AMP, and pyrophosphate[2]. It is a key enzyme in the anabolic utilization of ketone bodies, allowing tissues to synthesize cholesterol and fatty acids directly from ketone bodies, bypassing the citrate/ATP citrate lyase pathway. This pathway is particularly important in actively lipogenic tissues such as liver, adipose tissue, mammary gland, skin, intestinal mucosa, adrenals, and brain[2]. AACS is a member of the acyl-CoA synthetase family and is regulated in a tissue-specific manner according to lipid synthesis needs. Its structure and catalytic mechanism involve significant domain motions typical of adenylate-forming enzymes (ANL superfamily). Deficiencies or mutations in related enzymes can cause inherited metabolic disorders, especially those involving ketone body metabolism[3].

Other names
Acetoacetyl-CoA synthetaseAACSACSF1FLJ12389SUR-5Acyl-CoA synthetase family member 1Protein sur-5 homologacetoacetate-CoA ligasehomolog of C. elegans suppressor of ras 5 (sur-5)
02

Mechanism of action

Ligase catalysis (conversion of acetoacetate, CoA, and ATP to acetoacetyl-CoA, AMP, and pyrophosphate)

03

Biological functions

LipogenesisCholesterol biosynthesisFatty acid synthesisAnabolic utilization of ketone bodies (for de novo lipid synthesis)
04

Disease associations

Metabolic disorders (disorders of ketone body and isoleucine metabolism, potentially Acetoacetyl-CoA deficiency)Neurodevelopmental roles (via provision of cholesterol/lipids for neuronal development)Other (potential implications in cancer metabolism and lipid-related diseases – strong inference based on biosynthetic roles)
05

Safety considerations

Genetic disruptions lead to inborn errors of metabolism (inferred from known metabolic disorders involving related pathways)

Beyond the preview

Go deeper on Acetoacetyl-CoA synthetase (AACS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetoacetyl-CoA synthetase (AACS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call